Hengrui Pharmaceuticals Completes Share Buyback Totaling 13.75 Million A-Shares
Stock News
Jul 19
Hengrui Pharma (01276) has issued an announcement regarding the progress of its share repurchase program.
As of July 19, 2026, the company has cumulatively repurchased 13,750,200 of its A-shares through the centralized competitive bidding system of the Shanghai Stock Exchange.
The repurchased shares represent approximately 0.21% of the company's total share capital.
The highest price paid per share was RMB 70.00, while the lowest price was RMB 45.30.
The total amount paid for the repurchased shares was RMB 853 million, excluding transaction fees.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.